Financials
Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 168 M————— — Research & development —————— — Operating income 995 M790 M2.13 B775 M1.43 B2.75 B 7.09 B Non-Operating Income, Total 127 M89 M107 M113 M119 M99 M 438 M Interest expense, net of interest capitalized 477 M468 M301 M504 M488 M246 M 1.54 B Non-Operating Income, excl. Interest Expenses -350 M-379 M-194 M-391 M-369 M-147 M -1.1 B Unusual income/expense —————— — Pretax income 645 M289 M1.94 B384 M1.06 B2.6 B 5.99 B Equity in earnings —————— — Taxes 68 M-223 M448 M14 M175 M654 M 1.29 B Non-controlling/minority interest —————— — After tax other income/expense 22 M38 M28 M49 M46 M53 M 176 M Net income before discontinued operations 577 M408 M1.44 B343 M832 M1.85 B 4.46 B Discontinued operations —————— — Net income 577 M408 M1.44 B343 M832 M1.85 B 4.46 B Dilution adjustment -39 M-68 M———— — Preferred dividends 22 M22 M———— — Diluted net income available to common stockholders 516 M318 M1.44 B343 M832 M1.85 B 4.46 B Basic earnings per share (Basic EPS) 1.340.893.730.892.164.8 11.58 Diluted earnings per share (Diluted EPS) 1.320.893.720.892.164.78 11.55 Average basic shares outstanding 387 M386 M385 M385 M385 M385 M 1.54 B Diluted shares outstanding 390 M388 M386 M386 M386 M386 M 1.54 B EBITDA —————— — EBIT —————— — Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 729 M756 M742 M826 M862 M807 M 3.24 B